The Tissue Biospecimen and Pathology Resource (TBPR) is comprised of mature, highly functional CCSG supported shared facilities and provides all basic science, translational, clinical, and population science investigators at MD Anderson with access to human tissues that have been removed by therapeutic resection or biopsy with research consent, and advanced histologic services for characterization of human and animal research tissues. The TBPR supports hypothesis-generating, -developing, and -testing studies, including both correlative and integrated marker studies in clinical trials. The TBPR biorepository has six -80 freezers and three isothermal liquid nitrogen freezers in its centralized and monitored storage facility, and a - 80 freezer in each of the two Surgical Pathology suites. The TBPR research histology core includes specialized equipment for immunohistochemistry, fluorescent in situ hybridization (FISH), laser capture microdissection, and tissue microarray construction. 190,235 tissue specimens from 37,296 cases were collected during the current reporting period for Yrs 33-38, and 63,288 specimens were distributed to 152 investigators. Research histology usage grew by 5.2% from 174,015 units in 2007-2008 to 183,134 in 2011- 2012. Of the 152 total individual users of the TBPR biorepository, 86% of users had peer-reviewed funding, and 81.2% of 422 TBPR research histology users had peer-reviewed funding. 42% of the total operating budget for the TBPR is requested from the CCSG. Publications cited using the CCLC have appeared in Nature, Nature Med and J Clin Oncol. Institutional administrative support was provided by the Research Support Office in the Division of Pathology &Laboratory Medicine. Future plans include: establishing collaborative efforts with Lyndon B. Johnson Hospital and Banner MD Anderson to increase specimen collections from underserved and community patient populations;increasing sterile tissue collection and processing for vaccine clinical trials;increasing specimen collection in clinic procedure rooms and Interventional Radiology;collaborating with the Office of Biorepository Regulatory Support to standardize operations in all federated biorepositories at MD Anderson;enhancing Tissue Station integration with clinical and research protocol management databases;increasing the roster of available tissue biomarkers;and implementing a more efficient and multifunctional Laboratory Information Management System for charge backs, inventory monitoring, and workload reporting.

Public Health Relevance

The maintenance of a flexible, sophisticated institutional biorepository in conjunction with an advanced research histology core facility is vital to all aspects of current and future intra- and extramural clinical, translational, basic, and population-based research efforts at MD Anderson.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016672-39
Application #
8759780
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
39
Fiscal Year
2014
Total Cost
$797,780
Indirect Cost
$299,378
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Yu, Yao; Hu, Hao; Chen, Jiun-Sheng et al. (2018) Integrated case-control and somatic-germline interaction analyses of melanoma susceptibility genes. Biochim Biophys Acta Mol Basis Dis 1864:2247-2254
Melancon, Marites P; Appleton Figueira, Tomas; Fuentes, David T et al. (2018) Development of an Electroporation and Nanoparticle-based Therapeutic Platform for Bone Metastases. Radiology 286:149-157
Zhao, Hui; Zhang, Ning; Ho, Vivian et al. (2018) Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 through 2011. Cancer 124:679-687
Pan, Hubert Y; Jiang, Jing; Hoffman, Karen E et al. (2018) Comparative Toxicities and Cost of Intensity-Modulated Radiotherapy, Proton Radiation, and Stereotactic Body Radiotherapy Among Younger Men With Prostate Cancer. J Clin Oncol 36:1823-1830
Grossberg, Aaron J; Mohamed, Abdallah S R; Elhalawani, Hesham et al. (2018) Imaging and clinical data archive for head and neck squamous cell carcinoma patients treated with radiotherapy. Sci Data 5:180173
Lu, Zhimin; Hunter, Tony (2018) Metabolic Kinases Moonlighting as Protein Kinases. Trends Biochem Sci 43:301-310
Beadnell, Thomas C; Nassar, Kelsey W; Rose, Madison M et al. (2018) Src-mediated regulation of the PI3K pathway in advanced papillary and anaplastic thyroid cancer. Oncogenesis 7:23
Chen, Xiuhui; Mangala, Lingegowda S; Rodriguez-Aguayo, Cristian et al. (2018) RNA interference-based therapy and its delivery systems. Cancer Metastasis Rev 37:107-124
Kono, Miho; Fujii, Takeo; Matsuda, Naoko et al. (2018) Somatic mutations, clinicopathologic characteristics, and survival in patients with untreated breast cancer with bone-only and non-bone sites of first metastasis. J Cancer 9:3640-3646
Khouri, Issa F; Fernandez Curbelo, Irina; Turturro, Francesco et al. (2018) Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies. Clin Cancer Res 24:1011-1018

Showing the most recent 10 out of 12418 publications